United Therapeutics: Don't Fear The Patent Expiration Too Much
United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...
Is United Therapeutics (UTHR) The Most Expensive Stock Insiders Are Dumping In March?
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...
United Therapeutics (UTHR) Down 4.8% Since Last Earnings Report: Can It Rebound?
United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Reasons Investors Watch United Therapeutics (UTHR)
United Therapeutics shares have sunk to $308.27, producing a disappointing 14% loss - worse than the S&P 500’s 1.4% drop.
United Therapeutics Co. (NASDAQ:UTHR) Stock Position Raised by Envestnet Portfolio Solutions Inc.
Envestnet Portfolio Solutions Inc. boosted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 8.1% during the fourth quarter, according to its most recent Form 13F filing with the ...
Commonwealth Equity Services LLC Acquires 301 Shares of United Therapeutics Co. (NASDAQ:UTHR)
Commonwealth Equity Services LLC increased its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 3.7% during ...